
Common name
N-(2,6-dimethylphenyl)formamide
IUPAC name
N-(2,6-dimethylphenyl)formamide
SMILES
O=CNc1c(cccc1C)C
Common name
N-(2,6-dimethylphenyl)formamide
IUPAC name
N-(2,6-dimethylphenyl)formamide
SMILES
O=CNc1c(cccc1C)C
INCHI
InChI=1S/C9H11NO/c1-7-4-3-5-8(2)9(7)10-6-11/h3-6H,1-2H3,(H,10,11)
FORMULA
C9H11NO

Common name
N-(2,6-dimethylphenyl)formamide
IUPAC name
N-(2,6-dimethylphenyl)formamide
Molecular weight
149.190
clogP
2.124
clogS
-2.698
Frequency
0.0065
HBond Acceptor
1
HBond Donor
1
Total PolarSurface Area
29.1
Number of Rings
1
Rotatable Bond
1
Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
---|---|---|---|---|
FDBD00131 | Ranolazine |
![]() |
Cardiovascular Agents; Sodium Channel Blockers; Cardiovascular System; Cardiac Therapy; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of chronic angina. It should be used in combination with amlodipine, beta-blockers or nitrates. |
FDBD00168 | Lidocaine |
![]() |
Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Anesthetics, Local; Anesthetics; Respiratory System; Ophthalmologicals; Sensory Organs; Throat Preparations; Dermatologicals; Nervous System; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ib; Local Anesthetics; Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use; Vasoprotectives; Anesthetics for Topical Use; Antipruritics, Incl. Antihistamines, Anesthetics, Etc.; Amides; Analgesics and Anesthetics; Otologicals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; | For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks. |
FDBD00183 | Ropivacaine |
![]() |
Anesthetics, Local; Anesthetics; Nervous System; Amides; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | Used in obstetric anesthesia and regional anesthesia for surgery. |
FDBD00184 | Bupivacaine |
![]() |
Anesthetics, Local; Anesthetics; Nervous System; Amides; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures. |
FDBD00816 | Mepivacaine |
![]() |
Anesthetics, Local; Anesthetics; Nervous System; Amides; | For production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. |
FDBD00856 | Levobupivacaine |
![]() |
Anesthetics, Local; Anesthetics; Nervous System; Amides; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; CYP3A4 Inhibitors; | For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain management. |
FDBD00907 | Tocainide |
![]() |
Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ib; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; | For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. |
FDBD01609 | Etidocaine |
![]() |
Anesthetics, Local; Anesthetics; Nervous System; Amides; | |
FDBD02411 | delachlor |
![]() |
Herbicide | Herbicide |
FDBD02412 | dimethachlor |
![]() |
Herbicide | Herbicide |
19 ,
2
FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
---|---|---|---|---|---|
4kiq_ligand_1_1.mol2 | 4kiq | 0.941176 | -7.14 | c1(c(cccc1)NC=O)C | 10 |
3b2w_ligand_1_0.mol2 | 3b2w | 0.941176 | -6.90 | N(C=O)c1ccccc1C | 10 |
2nyr_ligand_1_2.mol2 | 2nyr | 0.941176 | -6.83 | N(C=O)c1ccccc1C | 10 |
4x3u_ligand_1_2.mol2 | 4x3u | 0.941176 | -6.70 | c1cc(c(cc1)C)NC=O | 10 |
4x3u_ligand_1_7.mol2 | 4x3u | 0.941176 | -6.70 | c1(ccccc1C)NC=O | 10 |
4nwm_ligand_1_5.mol2 | 4nwm | 0.941176 | -6.30 | c1ccc(c(c1)NC=O)C | 10 |
2h9t_ligand_1_2.mol2 | 2h9t | 0.941176 | -6.15 | N(C=O)c1ccccc1C | 10 |
2nyr_ligand_1_7.mol2 | 2nyr | 0.941176 | -5.90 | c1(ccccc1C)NC=O | 10 |
4yv5_ligand_1_2.mol2 | 4yv5 | 0.941176 | -5.75 | c1cc(c(cc1)C)NC=O | 10 |
307 ,
31